Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    14671984 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II
Conditions: Atrial Fibrillation;   Valvular Heart Disease;   Deep Vein Thrombosis;   Pulmonary Embolism;   Peripheral Arterial Disease
Intervention: Other: Prolonged interval between PT testing

Indicates status has not been verified in more than two years